Terms: = Breast cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Treatment
66 results:
1. Inactivation of the Tumor Suppressor cyld Sensitizes Mice to breast cancer Development.
Pseftogas A; Xanthopoulos K; Siasiaridis A; Poutahidis T; Gonidas C; Tsingotjidou A; Hatzivassiliou E; Mosialos G
Anticancer Res; 2024 May; 44(5):1885-1894. PubMed ID: 38677721
[TBL] [Abstract] [Full Text] [Related]
2. Propolis-loaded nanostructured lipid carriers halt breast cancer progression through miRNA-223 related pathways: an in-vitro/in-vivo experiment.
Shaker SA; Alshufta SM; Gowayed MA; El-Salamouni NS; Bassam SM; Megahed MA; El-Tahan RA
Sci Rep; 2023 Sep; 13(1):15752. PubMed ID: 37735586
[TBL] [Abstract] [Full Text] [Related]
3. Long-Term Risk of Being Bedridden in Elderly Patients Who Underwent Oncologic Surgery: A Retrospective Study Using a Japanese Claims Database.
Konishi T; Sasabuchi Y; Matsui H; Tanabe M; Seto Y; Yasunaga H
Ann Surg Oncol; 2023 Aug; 30(8):4604-4612. PubMed ID: 37149549
[TBL] [Abstract] [Full Text] [Related]
4. Distance to radiation therapy facility influences surgery type among older women with early-stage breast cancer.
Shrestha P; Chu QD; Hsieh MC; Yi Y; Peters ES; Trapido E; Yu Q; Ferguson T; Wu XC
Cancer Med; 2023 Mar; 12(6):6842-6852. PubMed ID: 36495041
[TBL] [Abstract] [Full Text] [Related]
5. Anticancer potential of Marina Crystal Minerals (MCM) against the growth of murine mammary adenocarcinoma cells in vivo.
Ghoneum M; Alaa El-Dein M; Badr El-Din NK
Biomed Pharmacother; 2023 Jan; 157():113975. PubMed ID: 36371853
[TBL] [Abstract] [Full Text] [Related]
6. Genistin modulates high-mobility group box protein 1 (HMGB1) and nuclear factor kappa-B (NF-κB) in Ehrlich-ascites-carcinoma-bearing mice.
Saleh MA; Antar SA; Abdo W; Ashour A; Zaki AA
Environ Sci Pollut Res Int; 2023 Jan; 30(1):966-978. PubMed ID: 35907070
[TBL] [Abstract] [Full Text] [Related]
7. Anticancer activity of chicken cathelicidin peptides against different types of cancer.
Mahmoud MM; Alenezi M; Al-Hejin AM; Abujamel TS; Aljoud F; Noorwali A; Awad IA; Alkhaled M; Yacoub HA
Mol Biol Rep; 2022 Jun; 49(6):4321-4339. PubMed ID: 35449320
[TBL] [Abstract] [Full Text] [Related]
8. The influence of antioxidant dietary-derived polyphenolic combination on breast cancer: Molecular study.
Alqarni AA; Alamoudi AA; Allam RM; Ajabnoor GM; Harakeh SM; Al-Abd AM
Biomed Pharmacother; 2022 May; 149():112835. PubMed ID: 35325850
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review.
Sun X; Wang X; Zhang J; Zhao Z; Feng X; Liu L; Ma Z
Breast; 2021 Dec; 60():26-34. PubMed ID: 34455227
[TBL] [Abstract] [Full Text] [Related]
10. treatment and survival outcomes of ceruminous carcinomas of the external auditory canal: a SEER database analysis and literature review.
Wanner B; Rismiller K; Carr DR
Arch Dermatol Res; 2022 Aug; 314(6):583-591. PubMed ID: 34160677
[TBL] [Abstract] [Full Text] [Related]
11. A five-gene signature for predicting overall survival of esophagus adenocarcinoma.
Lan T; Liu W; Lu Y; Luo H
Medicine (Baltimore); 2021 Apr; 100(14):e25305. PubMed ID: 33832101
[TBL] [Abstract] [Full Text] [Related]
12. Suppression of Molecular Targets and Antiproliferative Effect of Citronellal on Triple-Negative breast cancer Cells.
Fatima K; Luqman S
Curr Mol Pharmacol; 2021; 14(6):1156-1166. PubMed ID: 33687907
[TBL] [Abstract] [Full Text] [Related]
13. Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study.
Ishikawa T; Sakamaki K; Narui K; Nishimura H; Sangai T; Tamaki K; Hasegawa Y; Watanabe KI; Suganuma N; Michishita S; Sugae S; Aihara T; Tsugawa K; Kaise H; Taira N; Mukai H;
Breast; 2021 Apr; 56():70-77. PubMed ID: 33631458
[TBL] [Abstract] [Full Text] [Related]
14. Anti-cancer activity of two novel heterocyclic compounds through modulation of VEGFR and miR-122 in mice bearing Ehrlich ascites carcinoma.
Hazem RM; Mohamed AA; Ghareb N; Mehanna ET; Mesbah NM; Abo-Elmatty DM; Elgawish MS
Eur J Pharmacol; 2021 Feb; 892():173747. PubMed ID: 33232730
[TBL] [Abstract] [Full Text] [Related]
15. Anti-Metastatic Potential of a Novel Xanthone Sourced by Swertia chirata Against In Vivo and In Vitro breast Adenocarcinoma Frameworks.
Barua A; Choudhury P; Mandal S; Panda CK; Saha P
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2865-2875. PubMed ID: 33112542
[TBL] [Abstract] [Full Text] [Related]
16. Therapeutic potential of xanthones from
Barua A; Choudhury P; Mandal S; Panda CK; Saha P
Indian J Med Res; 2020 Sep; 152(3):285-295. PubMed ID: 33107489
[TBL] [Abstract] [Full Text] [Related]
17. ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in breast cancer Cells and Inhibits Tumor Progression in eac Mouse Tumor Models.
Nirgude S; Mahadeva R; Koroth J; Kumar S; Kumar KSS; Gopalakrishnan V; S Karki SS; Choudhary B
Molecules; 2020 Sep; 25(19):. PubMed ID: 33008036
[TBL] [Abstract] [Full Text] [Related]
18. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From breast cancer.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2020 Sep; 3(9):e2017124. PubMed ID: 32936299
[TBL] [Abstract] [Full Text] [Related]
19. Design and characterization of dual responsive mesoporous silica nanoparticles for breast cancer targeted therapy.
Bhavsar DB; Patel V; Sawant KK
Eur J Pharm Sci; 2020 Sep; 152():105428. PubMed ID: 32553643
[TBL] [Abstract] [Full Text] [Related]
20. Triaryl dicationic DNA minor-groove binders with antioxidant activity display cytotoxicity and induce apoptosis in breast cancer.
Nafie MS; Arafa K; Sedky NK; Alakhdar AA; Arafa RK
Chem Biol Interact; 2020 Jun; 324():109087. PubMed ID: 32294457
[TBL] [Abstract] [Full Text] [Related]
[Next]
